Analyst Price Targets — LFWD
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| August 16, 2024 6:39 am | Swayampakula Ramakanth | H.C. Wainwright | $156.00 | $45.60 | StreetInsider | Lifeward (LFWD) PT Raised to $13 at H.C. Wainwright |
| June 24, 2024 8:10 am | Ben Haynor | Lake Street | $102.00 | $49.68 | TheFly | Lifeward initiated with a Buy at Lake Street |
Latest News for LFWD
Lifeward Ltd. (NASDAQ: LFWD - Get Free Report) shares were up 2.5% on Thursday. The stock traded as high as $6.67 and last traded at $6.62. Approximately 4,146 shares changed hands during mid-day trading, a decline of 66% from the average daily volume of 12,257 shares. The stock had previously closed at $6.46. Analyst Upgrades
HUDSON, Mass. and YOKNEAM ILLIT, Israel, March 25, 2026 (GLOBE NEWSWIRE) -- Lifeward Ltd.
Lifeward Ltd. (LFWD) Q4 2025 Earnings Call Transcript
Advancing t ransformation into a d iversified b iomedical i nnovation c ompany with a c lear p ath to c ash f low p ositiv e Oramed s trategic t ransaction r eceives s hareholder a pproval ; Lifeward g ain s n ew o ral p rotein d elivery t echnology p latform Lifeward a lready e xecuting n ew s trategy t hrough a cquisition of p owered u pper- b ody e xoskeleton t echnology Lower operating expenses and cash usage…
Position s Lifeward as a diversified biomedical innovation company with clear path to profitability Integration of Oramed's POD™ oral delivery technology expands Lifeward into biotech markets while Oramed funds the platform's clinical development Provides Lifeward access to up to $47 million of capital HUDSON, Mass. and YOKNEAM ILLIT, Israel, March 13, 2026 (GLOBE NEWSWIRE) -- Lifeward Ltd.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for LFWD.
U.S. House Trading
No House trades found for LFWD.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.